CLASS II Device recall · Reported 3 Apr 2013 · FDA Enforcement Report

Architect HBsAg Qualitative Assay, List Number 4P53 recalled

Abbott Laboratories is recalling Architect HBsAg Qualitative Assay, List Number 4P53 and Architect HBsAg Qualitative, distributed nationwide in the US. The recall was initiated on 18 Dec 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll shipped out to this date
Quantity recalled12

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0987-2013
FDA event ID
63946
Recalling firm
Abbott Laboratories, Irving, TX
Classification
Class II
Status
Terminated
Recall initiated
18 Dec 2012
FDA classified
25 Mar 2013
Reported
3 Apr 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Hepatitis A

Timeline

18 Dec 2012Recall initiated by company
25 Mar 2013Classified by FDA+97 days
3 Apr 2013Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Abbott has identified that assay files for the ARCHITECT HBsAg Qualitative and HBsAg Qualitative Confirmatory assays (LNs 4P53 and 4P54) on the ARCHITECT i1000SR System were mistakenly made available on abbottdiagnostics.com in October 2012. Additionally, some i1000SR customers received notification through AbbottLink in November 2012 that assay files for LNs 4P53 and 4P54 were available. The AR

Product as listed by the FDA

ARCHITECT HBsAg Qualitative Assay, List Number 4P53 and ARCHITECT HBsAg Qualitative Confirmatory Assay, List Number 4P54 The ARCHITECT HBsAg Qualitative assay is a chemiluminescent microparticle immunoassay (CMIA) for the qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric serum and plasma and neonate serum.

Where it was distributed

Nationwide Distribution including AZ, CA, FL, GA, HI, LA, MA, MD, MO, NJ, NY, PA, RI, TN, TX, UT, and WA.

Nationwide ArizonaCaliforniaFloridaGeorgiaHawaiiLouisianaMassachusettsMarylandMissouriNew JerseyNew YorkPennsylvaniaRhode IslandTennesseeTexasUtahWashington

Questions about this recall

Is Architect HBsAg Qualitative Assay, List Number 4P53 and Architect HBsAg Qualitative recalled?

Yes. Abbott Laboratories recalled Architect HBsAg Qualitative Assay, List Number 4P53 and Architect HBsAg Qualitative on 18 Dec 2012. The recall is Class II and its status is Terminated. Recall number Z-0987-2013.

Why was it recalled?

Abbott has identified that assay files for the ARCHITECT HBsAg Qualitative and HBsAg Qualitative Confirmatory assays (LNs 4P53 and 4P54) on the ARCHITECT i1000SR System were mistakenly made available on abbottdiagnostics.com in October 2012. Additionally, some i1000SR customers received notification through AbbottLink in November 2012 that assay files for LNs 4P53 and 4P54 were available. The AR

Which lots are affected?

All shipped out to this date

Where was it sold?

Nationwide Distribution including AZ, CA, FL, GA, HI, LA, MA, MD, MO, NJ, NY, PA, RI, TN, TX, UT, and WA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Abbott Laboratories

All 153

Other Test Kits & Diagnostics recalls

All 2,656